JCacheStorageFile::_deleteFolder JFolder: :delete: Could not delete folder. Path: /home/bhi001/public_html/cache/mod_menu


Illumina Ventures, a San Francisco-based early-stage venture capital firm, closed its maiden fund, at $230m.

Launched with an initial $100m investment from Illumina, Illumina Ventures has then been supported by a mix of corporate, institutional, sovereign, and individual investors.


VLP Therapeutics, LLC (“VLP”), a biotechnology company focusing on the research and development of therapeutic and preventative vaccines announced today the receipt of a Phase I grant from the National Cancer Institute under auspices of the Small Business Innovation Research (SBIR) program of the National Institutes of Health. The $298,729 grant under the Award Number R43CA217445 is focused on “the development of a novel Virus-Like Particle vaccine-based cancer immunotherapy targeting PD-L1” and will also explore broader immune checkpoint inhibition mechanisms.


Brian Smith joined BHI in October of 2017 as a digital marketing and IT specialist. Brian manages BHI’s information technology assets in addition to serving as a marketing specialist for BHI and its client companies. Brian comes from a background in health science having earned his bachelor of science degree in human biology from Towson University. Before joining BHI, Brian was the principal of a small business that provided web information services and IT support to businesses in and around the metropolitan Washington DC area. Brian has an enthusiasm for entrepreneurialism and draws from experience working in both clinical research and biomanufacturing.


As the leaves settle on the ground, so do the newest Venture for America fellows into the place they’ll call home for the next two years. The food hall R. House, which was spearheaded by two VFA Fellows, hosted the full group last week, giving new fellows had the chance to mingle and chow down on gourmet hors d’oeuvres with the current cohort and local community of supporters.


What began as a kind of business experiment in innovation has acquired a life of its own.

The idea in 2011 was to create a space at what was then Johnson & Johnson’s pharmaceutical research and development facility in San Diego for an “innovation center,” a place where 18 to 20 life sciences startups could incubate, replete with lab space and equipment. J&J would screen applicants and charge them to lease the space, but would not require an ownership stake or impose licensing requirements on the startups. It would be a “no strings attached” deal.


Infosecurity Group, the founders of Europe’s no.1 information security event, is pleased to announce Inky as the Infosecurity North America Cyber Start-up Company of the Year 2017. Four start-ups competed today during Infosecurity North America 2017 Expo and Conference, presenting their elevator pitches to a judging panel of venture capitalists. 


The Association of University Research Parks (AURP) today announced the recipients of the Awards of Excellence recognized during its 2017 International Conference hosted by Cummings Research Park in Huntsville, AL. Additionally, AURP announced the results of the election for its 2018 Board of Directors.